TechU Ventures — Full Portfolio
4 tracked investments · listed companies and verified rows first
Boulder-based preclinical biotech using human-cell directed evolution to create target-degrading antibodies and next-generation ADCs.
Boulder, US
Doug Chapnick(Founder)in
BoardJoel Dudley(Director)inNicholas Saccomano(Director)
Co-investorsBoxOne VenturesHorizons VenturesBoom Capital VenturesInnovation Endeavors
Naveris develops and commercializes liquid biopsy tests for the early detection and monitoring of HPV-associated cancers, particularly head and neck and anal cancers.
BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesWaltham, US
James McNally(Executive Officer, Director)inPiyush Gupta(Executive Officer, Director)
BoardAnne Stone(Director)Francis Crispino(Director)Philip Grahame Haydon(Director)
Co-investorsGurnet Point Capital
RreviveMed applies artificial intelligence to metabolomics and biology to support drug discovery in the pharmaceutical and biotech sector.
AI & Machine LearningBiotechHealthtechCambridge, US
Leila Pirhaji(Executive Officer, Director)inAndrey Zarur(Director)inCarlos Gonzalez(Director)Ernest Fraenkel(Director)in
Co-investorsGood Growth CapitalMassChallengeTeam Builder VenturesWorldQuant Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.